$TDOC

Teladoc Health, Inc.

Teladoc Health provides virtual healthcare services and technology to individuals, employers, health plans, hospitals, health systems and other partners. Its Integrated Care segment offers virtual preventive, primary, urgent, mental health, chronic care and expert second-opinion services, and connected-care technology for hospitals and health systems. Its BetterHelp segment provides online counseling and therapy through a network of licensed clinicians, with web, mobile app, phone and text-based interactions. The company also offers the BetterSleep app. Teladoc Health serves customers through business-to-business and direct-to-consumer channels, with access to care available 24 hours a day, 7 days a week, and 365 days a year. It primarily earns recurring access fees from clients, as well as fees for telehealth visits, software licenses, implementation, hardware and related services. BetterHelp primarily earns weekly or monthly fees from users who pay directly or use insurance. Teladoc Health is headquartered in New York, NY.

2
0
0
—
$271K
Nueno Carlos
100%
See all $TDOC insider activity →
Low

Teladoc Health (TDOC) Adds Employer Contribution Option for GLP-1 Drugs

Teladoc Health (TDOC) introduced an employer contribution option for GLP-1 drugs in its Comprehensive Weight Care program. Employers can set fixed payments per employee per fill, with the first clients launching Jan. 1, 2027. This expands the company's existing weight-care services, following a self-pay option introduced last year.

Online marketplace stocks Q3 recap: Benchmarking LegalZoom

Online marketplace stocks reported mixed Q3 results. LegalZoom (LZ) saw a 2.6% revenue increase but missed EBITDA guidance, with shares down 27.7%. EverQuote (EVER) reported a 25.4% revenue growth, beating estimates, and shares up 16.6%. Cars.com (CARS) revenues were flat, missing expectations, with shares unchanged. Etsy (ETSY) grew revenues by 10.9%, beating estimates, and shares up 1.5%. Teladoc (TDOC) revenues declined 3.4% but beat estimates, with shares up 28.7%.

TDOC sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning TDOC (Teladoc Health, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.

Recent TDOC coverage spans financial news, earnings and sector analysis.

In the last 30 days, TDOC insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($271K). The most active reporter was Nueno Carlos, President, International, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving TDOC

AlphAI scores every news story that mentions TDOC with an AI model for sentiment and relevance, and aggregates insider trades from Teladoc Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TDOC

Score

Online marketplace stocks Q3 recap: Benchmarking LegalZoom

Online marketplace stocks reported mixed Q3 results. LegalZoom (LZ) saw a 2.6% revenue increase but missed EBITDA guidance, with shares down 27.7%. EverQuote (EVER) reported a 25.4% revenue growth, beating estimates, and shares up 16.6%. Cars.com (CARS) revenues were flat, missing expectations, with shares unchanged. Etsy (ETSY) grew revenues by 10.9%, beating estimates, and shares up 1.5%. Teladoc (TDOC) revenues declined 3.4% but beat estimates, with shares up 28.7%.

TDOC Q3 deep dive: insurance-fueled BetterHelp pivot offsets cash pay headwinds, new care model launches

Teladoc (TDOC) reported Q3 revenue of $605.1M, beating estimates, with EPS and EBITDA also exceeding expectations. BetterHelp's insurance transition progressed, with insurance-covered sessions reaching $140M annualized revenue. The company launched Teladoc 1, a new care model, and expanded its therapist network. Q4 revenue guidance was slightly below estimates, but full-year EPS and EBITDA guidance beat expectations. Management highlighted insurance-driven growth and cost management efforts.

UBS raises Teladoc stock price target on margin improvement

UBS raised its price target for Teladoc Health (NYSE:TDOC) to $9.00 from $6.50, citing margin improvements. The stock trades at $8.51, with a Fair Value of $11.80 according to InvestingPro. UBS maintained a Neutral rating due to competitive pressures. Teladoc's Q3 2026 results beat expectations, with revenue of $605.1 million and a smaller loss per share. The company raised its full-year revenue and EBITDA guidance.

Related tickers